SUBSCRIBE
SUBSCRIBE
News   Deals

Pantarhei to Bid for Merck & Co., Inc.'s Organon Unit

February 14, 2011 | 
1 min read
Reuters) - Dutch bioscience company Pantarhei intends to bid for the bulk of U.S. company Merck's (MRK.N) Netherlands-based bioscience research unit Organan, the Dutch Financieele Dagblad reported on Monday.
Mergers & acquisitions Europe
Merck & Co. Organon
MORE ON THIS TOPIC
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Neuroscience
Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
September 3, 2025
 · 
6 min read
 · 
Annalee Armstrong
A red paper airplane with a fighter jet shadow changes course from a group of other paper airplanes, a concept of different business and social behaviors. Vector illustration.
IPO
After Short Stint as a Private Company, BBOT Leaves SPAC Process Ready To Execute
September 3, 2025
 · 
3 min read
 · 
Annalee Armstrong
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie